- Researcher Spotlight Series
- CoMH Research and Innovation Committee
- APC Microbiome Institute
- Biosciences Imaging Centre
- Centre for Gerontology & Rehabilitation
- Centre for Research in Vascular Biology
- Cork NeuroScience Centre
- Cancer Research @UCC
- HRB Clinical Research Facility Cork
- National Perinatal Epidemiology Centre
- Oral Health Services Research Centre
- HRB Centre for Health & Diet Research
- ENTO (Ear, Nose, Throat and Oral Research Unit)
- Continuing Professional Development
- Hospital Partners
- Community Partners
- Jennings Gallery
- Graduate Studies
- Postgraduate Programmes
- News & Events
- Postgraduate Supports
- Employment-based PhD Scholarships for Health Science Professionals
- Policies and Procedures
- Postgraduate Student Committee
- Supervisor Information
- Postgraduate Skills Development
- Student Testimonials
- Research Funding and Travel Bursaries
- Programmes for International (Non-EU) Students
- iEd Hub
- Inaugural Lecture Series
- UCC Academic Health Sciences
Professor Roisin Connolly
Translational Cancer Research: Improving Treatment Decision-Making and Patient Outcomes
Tuesday 21st September 2021, 3pm to 4pm
Professor Connolly is a medical oncologist and clinical investigator with expertise in the development of biomarkers of response to anti-cancer therapies, and the design and conduct of clinical trials that test investigational new drugs in the treatment of patients with both early- and late-stage cancers. This inaugural lecture will focus on advances in HER2-positive breast cancer, ER-positive breast cancer and the area of survivorship; through translational and collaborative cancer research efforts.
Professor Roisin Connolly was appointed as the Professor Gerald O’Sullivan Chair in Cancer Research at University College Cork (UCC) and Cork University Hospital in September 2019. Prior to same, Roisin was an Associate Professor of Oncology (Breast and Ovarian Cancer Program) and Co-Director of the Developmental Therapeutics Program at the Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins, US and continues to hold an adjunct position. She graduated with a 1st class honors medical degree from Trinity College, Dublin in 2001 and completed medical oncology fellowship training in both Ireland and at Johns Hopkins.
Professor Connolly is a medical oncologist and clinical investigator with expertise in the development of biomarkers of response to anti-cancer therapies, and the design and conduct of clinical trials that test investigational new drugs in the treatment of patients with both early- and late-stage cancers. She has led numerous multicenter clinical trials in collaboration with the Cancer Therapy Evaluation Program (CTEP) at the National Cancer Institute (NCI), the Translational Breast Cancer Research Consortium (TBCRC), and the Eastern Co-operative Oncology Group (ECOG)-ACRIN in the US. Professor Connolly is Study Chair for the international phase III ECOG-ACRIN study (E2112) investigating the epigenetic agent entinostat in combination with hormonal therapy in patients with metastatic breast cancer. She recently received the prestigious ECOG-ACRIN Young Investigator Award 2019 for excellence in clinical investigation.
Roisin is Director of Cancer Research @UCC and a Principal Investigator with Cancer Trials Cork at CUH. In 2020, Prof Connolly took on the role of Co-Chair of the Cancer Trials Ireland Breast Disease Specific Group and is Lead Applicant for a proposed Health Research Board funded UCC Cancer Trials Cluster. She recently received an Irish Cancer Society grant to support a Women’s Cancer Survivorship Clinic in Cork, which she is leading with Professor Josephine Hegarty (School of Nursing) and multiple collaborators across the region. Her goal is to improve outcomes for patients with cancer through innovative clinical and translational research, in collaboration with UCC, national and international researchers.
Learn more about Prof Connolly's research interests and publications at the below link.